Management attributes the current performance to a deliberate shift toward higher-value technology solutions, with AI-related bookings more than doubling sequentially.

The proprietary iX suite is serving as a strategic 'door opener' for large, transformative enterprise deals, including new contracts with two Fortune 50 companies.

Revenue growth in Banking and Financial Services (13%) was driven by a successful expansion into complex work and technology services that were historically handled in-house.

Management acknowledges that initial AI implementations can compress margins due to consumption-based pricing models, but these become accretive once programs reach full production scale.

The decline in Technology and Healthcare verticals (both down 6%) is attributed to lighter-than-expected client volumes and a continued shift in the delivery mix toward offshore locations.

The company sold two small, non-strategic businesses to focus resources on higher-growth and higher-profit areas, though management indicated no further divestitures are currently imminent.

Management expects sequential margin expansion in the second half of 2026, supported by $40 million in annualized savings from restructuring actions taken in Q1 and Q2.

Revenue guidance for Q2 assumes a conservative stance due to global geopolitical uncertainties, despite a solid overall demand environment.

The company targets reaching $100 million in AI-related Annual Recurring Revenue (ARR) by the end of the fiscal year, up from $60 million at the end of 2025.

Financial strategy focuses on aggressive deleveraging, with a commitment to reduce net leverage to below 2.6x adjusted EBITDA by year-end using robust free cash flow.

The transition of work to offshore locations is expected to remain a 2-point revenue headwind for the year but will eventually serve as a tailwind for long-term margin improvement.

A $6 million GAAP loss was recorded on the sale of non-core assets, with total proceeds from business and property sales expected to reach $40 million.

Excess physical capacity negatively impacted margins by 20 to 40 basis points this quarter; management expects to recover this as new volume fills that capacity in the second half.

The company successfully refinanced $600 million in debt to manage upcoming maturities, maintaining a liquidity position of nearly $1.4 billion.

Direct exposure to Middle Eastern geopolitical volatility is limited to approximately 1% of total revenue.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

The 'iX Hello' autonomous solution uses consumption-based pricing, while the 'Hero' agent-assist product follows a per-seat subscription model.

Management noted that while many competitors talk about AI, Concentrix is seeing 'very high success rates' in actual implementations driving tangible client value.

Management expressed confidence in returning to historical margin levels by scaling AI programs and realizing synergies from the Webhelp integration.

The Q4 margin is expected to show a significant step-up as cost actions and higher-margin technology revenue streams reach full run-rate.

Healthcare weakness is tied to specific changes in Medicare and Affordable Care Act membership among clients, which may take several quarters to stabilize.

Tech vertical volatility is a mix of underlying volume softness and the intentional shift of work to lower-cost offshore regions.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.